Latest Phenols Stories

Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain

2013-05-21 08:28:38

- Following major orthopedic surgery, Sufentanil NanoTab-treated patients experienced significantly greater reduction in pain as measured by SPID-48 vs. placebo (p

New Natural Vitiligo Treatment System That Helps People Treat Vitiligo Permanently Revealed by Daily Gossip Magazine

2013-05-20 23:01:58

DailyGossip.org lends a helping hand to readers suffering of vitiligo by exposing the secrets of a revolutionary natural vitiligo cure. Denver, Colorado (PRWEB) May 20, 2013 Daily Gossip, online magazine about lifestyle, health and sports issues, is willing to provide its readers with useful tips that can help them overcome one of the most spread skin affection, vitiligo. According to the website Natural Vitiligo Treatment System has created a buzz on the Internet due to the numerous...

Statement by Farah Ahmed, Chair, Personal Care Products Council Sunscreen Committee, In Response to the Environmental Working Group's 2013 Sunscreen Report

2013-05-20 00:21:34

WASHINGTON, May 20, 2013 /PRNewswire/ -- "In a matter of days, Americans will begin the official start of the summer season by celebrating Memorial Day at beaches, pools and parks. Before they walk outside, we want them to apply sunscreen to protect themselves and their families from the damaging effects of sun exposure. Sunscreen products, when used as directed and as part of an overall safe sun regimen, are safe and help reduce the risk of skin cancer, premature skin aging, and...

New Study Shows Effect of Neupro® (Rotigotine Transdermal System) on Cardiovascular Measures in Patients with Restless Legs Syndrome

2013-05-17 04:20:33

Data Showed Reduced Nocturnal Systolic Blood Pressure Elevations and Periodic Limb Movements During Sleep in Restless Legs Syndrome (RLS) Patients ATLANTA, May 17, 2013 /PRNewswire/ -- UCB today announced data from a double-blind, placebo-controlled study that found that Neupro(®) (Rotigotine Transdermal System) reduced total nocturnal systolic blood pressure (NSBP) elevations associated with periodic limb movements during sleep (PLMS) and total PLMS in patients with idiopathic...

Erectile Dysfunction More Common in Men Who Regularly Take Prescription Painkillers

2013-05-15 12:34:35

Kaiser Permanente study first to use electronic health records to document link between prescription opioid use and ED prescriptions PORTLAND, Ore., May 15, 2013 /PRNewswire/ -- Regularly taking prescription painkillers, also known as opioids, is associated with a higher risk of erectile dysfunction, according to a study published online today in the journal Spine. The researchers included more than 11,000 men with back pain in the study and examined their health records to...

Plandai Biotechnology, Inc. Announces Positive Anti-Malaria Test Results Using Phytofare(TM) Extract

2013-05-15 12:33:08

Further tests to commence regarding use as potential vaccine SEATTLE, May 15, 2013 /PRNewswire/ -- Plandai Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical and pharmaceutical, today announced that the Company's Phytofare(TM) Catechin Extract has proven effective in killing the malaria parasite, plasmodium falciparum, in analytical tests developed by and conducted under the supervision of Dr....

Study Shows Honokiol Supports Muscles During Intense Exercise*

2013-05-14 08:32:04

Versatile herbal extract controls normal exercise-related inflammation* SANTA ROSA, Calif., May 14, 2013 /PRNewswire/ -- Honokiol is a powerful polyphenol compound extracted from Magnolia officinalis bark. Extensive pre-clinical research shows that honokiol (pronounced ha-no-kee-ohl) supports cellular health and provides gentle relaxation, as well as being a potent antioxidant. In addition, a study published in the European Journal of Pharmacology has found that the botanical...

Endo Health Solutions Responds to FDA's Denial of OPANA® ER Citizen Petition and the Potential Approval of Additional Non-Abuse Deterrent Formulations of Generic Oxymorphone

2013-05-10 16:25:10

MALVERN, Pa., May 10, 2013 /PRNewswire/ -- Endo Health Solutions Inc. (Nasdaq: ENDP) announced today that the U.S. Food and Drug Administration (FDA) has denied a Citizen Petition filed by its subsidiary, Endo Pharmaceuticals Inc. Endo presented FDA data collected from an ongoing epidemiology study that indicate that per 100,000 prescriptions dispensed, the past 30-day abuse rate of crush-resistant OPANA ER was 79 percent lower than the abuse rate of generic versions of...

Behavioral Health Group (BHG) Outpatient Opioid Treatment Centers Offer New Medication Option for Patients

2013-05-08 16:27:10

DALLAS, May 8, 2013 /PRNewswire/ -- Michael Cannizzaro, Behavioral Health Group (BHG) Chairman and Chief Executive Officer, announced that BHG treatment centers are now offering both Buprenorphine and Methadone in their medication-assisted treatment programs. Mr. Cannizzaro said, "BHG's outpatient opioid addiction treatment centers address each patient's physical opioid addiction with either Methadone or Buprenorphine medications in combination with counseling and skill...

Collegium Announces Poster Presentation for Oxycodone DETERx®, an Abuse-Deterrent, Extended-Release Opioid at American Pain Society's 32nd Annual Scientific Meeting

2013-05-08 08:30:13

CANTON, Mass., May 8, 2013 /PRNewswire/ -- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, today announced the presentation of a scientific poster titled "Oxycodone DETERx®, an Extended-release, Abuse-deterrent Formulation for the Management of Chronic Pain," at the American Pain Society's 32(nd) Annual Scientific Meeting, held in New Orleans, Louisiana from May 8(th) to May 10(th). This...